🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to all of the investigators that participated in INTREPID to help deliver an important result for the critical care and stroke community! Yale School of Medicine jamanetwork.com/journals/jama/…

Alva Health and I are asking for your support! 📷 Alva Health is honored to be part of the American Heart Association’s #EmpoweredToServe Business Accelerator, working to make a real impact in health equity through innovation in stroke detection and care.  Help us win a $5K

Yale team American Heart Association Bugher Foundation Meeting! Yale Neuroscience Guido J. Falcone MD, ScD, MPH LaurenHSansing Kevin Sheth Yale Neurocritical Care

🚀 Join Yale's Cutting-Edge Brain & AI Research Team! 🧠✨ Yale's Center for Brain & Mind Health (CBMH) is hiring at all levels to lead innovative AI-driven neuroscience! We're seeking passionate researchers applying AI to brain health challenges. Don’t miss the chance to shape

#STROKE: Among hospitals participating in the GWTG-Stroke program, there has been a sustained improvement in quality of care for patients with stroke and TIA. #AHAJournals ahajournals.org/doi/10.1161/ST… Gregg Fonarow MD Ying Xian @braindoc_mgh Eric_Smith_VCI @Ramondata Chandler Beon Kevin Sheth

See our work with W. Taylor Kimberly in The Lancet Neurology! The CHARM trial represents a significant step toward tackling cerebral edema in large hemispheric strokes. Yale School of Medicine Yale University AHA Science NIH StrokeNet thelancet.com/journals/laneu… While challenges remain, the findings inspire

And a tease about what might be next? Well, let's see if we can recapitulate the following from CHARM in a new trial and then we have something special. W. Taylor Kimberly

Just published—portable, low-field MRI can detect brain changes associated with Alzheimer’s disease. And scanning can be done conveniently in the clinic. Dr Annabel Sorby-Adams Kevin Sheth Matt Rosen Juan Eugenio Iglesias @MGH_RI MassGeneralNeuroscience #FUNDING Alzheimer's Association nature.com/articles/s4146…

Apixaban compared to aspirin was associated with fewer incident nonlacunar covert infarcts among patients with a recent cryptogenic ischemic stroke and atrial cardiopathy. Kevin Sheth ja.ma/4jxC0Bi

Excited to share our study on epigenetic clocks and brain health. We show a biderectional relationship between epigenetic age and risk of several brain health outcomes. Paper nature.com/articles/s4146… #YaleCBMH Yale Neurology Yale Pepper Center

Very proud of this guy ... CONGRATULATIONS Cyprien Rivier ! ! ! For receiving the Vascular Cognitive Impairment Award @ #ISC25 for the abstract "Integrated Genomic/Proteomic Profiling Supports Cathepsin-B as a Drug Target in CSVD” isc.hub.heart.org/daily-coverage… Yale Neurology

Thank you to the Stroke AHA/ASA for showcasing our research on minimally invasive surgery after ICH. Weill Cornell Neurology

Can surgery help more patients with brain hemorrhage (ICH) than we thought? Our new paper in Stroke AHA/ASA explores real-world outcomes across the U.S., thanks to the power of data and team science. #StrokeTwitter #ICH #NeuroTwitter #Neurosurgery #TeamScience AHA Science

Breakthrough in stroke treatment! A new CHARM trial analysis shows i.v. glyburide may improve outcomes in large-core stroke patients, especially with thrombectomy. Odds of better recovery soar to 8.19! #Stroke #Neurology #neurotwitter Yale School of Medicine W. Taylor Kimberly Raul G Nogueira, MD, FAHA, FSVIN